But it has been hard to attract interest in medical interventions for viruses that have not been considered a top public ...
As state leaders change laws to make vaccines more accessible, a coalition of doctors, public health advocates and everyday ...
After a large trial showed stronger protection, regulators are weighing whether Moderna’s mRNA vaccine could become a U.S.
The agency’s scientists and data contractors reviewed millions of patient records for studies that were pulled back before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results